Seattle biotech Kineta teams up with Genentech to create chronic pain medicine

Favicon The Seattle Times

Kineta could receive more than $359 million as a result of the deal.

Read the full article here: The Seattle Times


The post: «Seattle biotech Kineta teams up with Genentech to create chronic pain medicine» has been published on the website The Seattle Times where, everyday, you can find the latest news about Seattle's area.



Get more articles about this topic

Leave a comment